Summary
Contrast media injectors are regularly used in radiology to inject contrast media agents into the bloodstream of patients in order to enable clear visualization of various pathologies. Contrast media injectors are used in hospitals in tandem with X-ray, CT, MRI and other scanners, and can be specialized by imaging device or designed for general compatibility. The market outlook for contrast media injectors is strongly driven by the increasing number of annual diagnostic systems across all diagnostic imaging modalities. This report will identify the unmet needs with current devices, discuss current and future technological trends, and analyse the contrast media injector market’s outlook by geography and segment. This report examines the contrast media injector market in the three major North American markets: Canada, Mexico, and the US.
This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the North American market. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of contrast media injectors.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Highlights
Key Questions Answered
- What is the current and future contrast media injector market outlook in North America? What trends are affecting the North American market?
- What is the competitive landscape and market share of major players in the contrast media injector space in North America?
- What are the key, high growth markets that contrast media injector manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the contrast media injectors currently on the market? How will emerging technologies fulfill these unmet needs?
- What is physician perception and market outlook of contrast media injectors?
- What are the challenges and barriers that have hindered widespread adoption of contrast media injectors?
Reasons to buy
- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Companies Mentioned
Bayer AG
Bracco Diagnostics
Guerbet SA
ulrich GmbH & Co. KG
Nemoto Kyorindo
'
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Metrics in Major Markets
2.2 Market Dynamics
2.2.1 Technological Trends
2.2.2 Key Players
2.3 Global Market Future Outlook
2.4 What Do Physicians Think?
3 Introduction
3.1 Overview
3.1.1 CT Injectors
3.1.2 MRI Injectors
3.1.3 Angiographic Injectors
3.1.4 Safety Concerns
3.2 The Global Market
3.3 Catalyst
3.4 Related Reports
4 Market Access
4.1 Reimbursement
4.2 Regulatory Developments
4.3 M&A/Key Partnerships
5 Procedure Trends
5.1 Overview
5.1.1 Syringeless Injectors
5.1.2 Multidosing
5.1.3 Information Technology
5.1.4 Medical Tourism
6 Unmet Needs
6.1 Overview
6.1.1 Lower Initial Costs
7 Competitive Assessment
7.1 Company Share Analysis
7.1.1 North America Market Share Analysis
7.2 Major Players
7.2.1 Bayer AG
7.2.2 Bracco Diagnostics
7.2.3 Guerbet SA
7.2.4 ulrich GmbH & Co. KG
7.2.5 Nemoto Kyorindo
7.2.6 Other Companies
7.3 Emerging Players
8 Market Outlooks
8.1 Market Drivers and Barriers
8.1.1 Driver: Workflow Optimization
8.1.2 Driver: Contrast Agent Waste Management
8.1.3 Driver: Imaging Systems
8.1.4 Driver: Patient Safety
8.1.5 Driver: Aging Populations
8.1.6 Barrier: Price Competition
8.1.7 Barrier: Manual Injectors
8.1.8 Barrier: OEM Partnerships
8.1.9 Barrier: Innovation
8.1.10 Barrier: Product Lifespan
8.2 Market Outlooks by Segment
8.2.1 CT Injectors
8.2.2 MRI Injectors
8.2.3 Angio Injectors
8.3 Market Outlooks by Geography
8.3.1 US Market Outlook
8.3.2 Canada Market Outlook
8.3.3 Mexico Market Outlook
9 Appendix
9.1 Bibliography
9.2 Abbreviations
9.3 Methodology
9.3.1 Overview
9.3.2 Coverage
9.3.3 Physician Survey
9.3.4 Expert Panel Validation
9.3.5 Secondary Research
9.4 Forecasting Methodology
9.5 Primary Research Efforts
9.6 About the Authors
9.6.1 Sarah Janer, Analyst- Medical Devices
9.6.2 David Brady, Director of Operations - Market Research
9.6.3 Tyler Fletcher, Global Head of Medical Devices
9.7 About GlobalData
9.8 Contact Us
9.9 Disclaimer
1.1 List of Tables
Table 1: Contrast Media Injectors Key Metrics: Key Events and Pipeline Assessment
Table 2: North America and Brazil’s Reimbursement Agencies
Table 3: Contrast Media Injectors Regulatory Issues and Recalls
Table 4: Mergers and Acquisitions
Table 5: Company profile - Bayer AG
Table 6 : Bayer AG’s Featured Contrast Injector Models
Table 7: SWOT Analysis - Bayer AG
Table 8: Company profile - Bracco S.p.A.
Table 9: Bracco S.p.A.’s Featured Contrast Injector Models
Table 10: SWOT Analysis - Bracco S.p.A.
Table 11: Company profile - Guerbet SA
Table 12: Guerbet SA’s Featured Contrast Injector Models
Table 13: SWOT Analysis - Guerbet SA
Table 14: Company profile - ulrich GmbH & Co. KG
Table 15: ulrich GmbH & Co. KG’s Featured Contrast Injector Models
Table 16: SWOT Analysis - ulrich Gmbh & Co. KG
Table 17: Company profile - Nemoto Kyorindo
Table 18: Nemoto Kyorindo’s Featured Contrast Injector Models
Table 19: SWOT Analysis - Nemoto Kyorindo
Table 20: Other Contrast Media Injector Companies
Table 21: Angiodroid America Inc.’s Featured Contrast Injector Models
Table 22: SWOT Analysis - Angiodroid America
Table 23: AngioDynamics Featured Contrast Injector Models
Table 24: SWOT Analysis - AngioDynamics
Table 25: Apollo RT Co., Limited’s Featured Contrast Injector Models
Table 26: SWOT Analysis - Apollo RT Co., Limited
Table 27: Global Market Value Forecast for Contrast Media Injectors $M, 2012-2022
Table 28: Global Market Value Forecast for CT Injectors, $M, 2012-2022
Table 29: Global Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 30: Global Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 31: North America Market Value Forecast for All Segments $M, 2012-2022
Table 32: US Market Volume Forecast by Segment, 2012-2022
Table 33 US Market Value Forecast for CT Injectors, $M, 2012-2022
Table 34: US Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 35: US Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 36: Canada Market Volume Forecast by Segment, 2012-2022
Table 37: Canada Market Value Forecast for CT Injectors, $M, 2012-2022
Table 38: Canada Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 39: Canada Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 40: US Market Volume Forecast by Segment, 2012-2022
Table 41: Mexico Market Value Forecast for CT Injectors, $M, 2012-2022
Table 42: Mexico Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 43: Mexico Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 44: Physicians Surveyed, By Country
Table 45: Primary Research Interviews Completed
1.2 List of Figures
Figure 1: Contrast Media Global Market Share Comparison by Major Market, 2015 and 2022 Forecast
Figure 2: Automatic and Manual Contrast Media Injectors
Figure 3: Types of CT Injectors by Syringe Model
Figure 4: Effect of a Saline Chaser on the Radio density of an Iodine Contrast Agent
Figure 5: Cerebral Angiography of Arteria Vertebralis, Sinister Injection
Figure 6: Global Contrast Media Injector Revenue Market Share 2015
Figure 7: Global Market Share of the Contrast Media Injector Market in 2015 (%)
Figure 8: North America Market Share of the Contrast Media Injector Market in 2015 (%)
Figure 9 : Average Number of Contrast Media Injectors Sold Per Diagnostic Imaging Device Type in 2016
Figure 10: Manual Contrast Injector and Power Contrast Injector Use by Country 2015
Figure 11: Global Market Value Forecast by Market Segment for Contrast Media Injectors, $m, 2012-2021
Figure 12: Global Market Value Forecast for Single and Dual Head Injectors, $M, 2012-2022
Figure 13: Global Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 14: Global Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 15: North America and Brazil Market Value Forecast by Market Segment for Contrast Media Injectors, $M, 2012-2022
Figure 16: US Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 17: US Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 18: US Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 19: US Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 20: Canada Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 21: Canada Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 22: Canada Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 23: Canada Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 24: Mexico Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 25: Mexico Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 26: Mexico Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 27: Mexico Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
